Figure 2.
HLA-A0201–restricted recognition of fibromodulin-derived peptides presented on T2 cells by expanded T cells from 8 CLL patients. The numbers of spots detected and presented in Table 2 were pooled to show the immunogenicity of the 4 fibromodulin-derived peptides and the HLA-A0201 restriction of the T cells by blockade with an anti-MHC class I mAb (W6/32).

HLA-A0201–restricted recognition of fibromodulin-derived peptides presented on T2 cells by expanded T cells from 8 CLL patients. The numbers of spots detected and presented in Table 2 were pooled to show the immunogenicity of the 4 fibromodulin-derived peptides and the HLA-A0201 restriction of the T cells by blockade with an anti-MHC class I mAb (W6/32).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal